Deutsche Bank’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.9M Sell
135,969
-20,283
-13% -$284K ﹤0.01% 1729
2025
Q1
$2.13M Sell
156,252
-121,601
-44% -$1.65M ﹤0.01% 1689
2024
Q4
$5.66M Buy
277,853
+37,907
+16% +$773K ﹤0.01% 1271
2024
Q3
$6.99M Buy
239,946
+16,546
+7% +$482K ﹤0.01% 1135
2024
Q2
$5.19M Sell
223,400
-7,031
-3% -$163K ﹤0.01% 1223
2024
Q1
$4.73M Buy
230,431
+115,079
+100% +$2.36M ﹤0.01% 1276
2023
Q4
$2.48M Sell
115,352
-1,146
-1% -$24.6K ﹤0.01% 1549
2023
Q3
$2.4M Sell
116,498
-28,379
-20% -$585K ﹤0.01% 1274
2023
Q2
$4.28M Buy
144,877
+14,148
+11% +$418K ﹤0.01% 1298
2023
Q1
$3.01M Buy
130,729
+19,999
+18% +$461K ﹤0.01% 1460
2022
Q4
$3.08M Buy
110,730
+9,880
+10% +$275K ﹤0.01% 1425
2022
Q3
$3.1M Sell
100,850
-9,447
-9% -$290K ﹤0.01% 1410
2022
Q2
$3.25M Sell
110,297
-2,617
-2% -$77K ﹤0.01% 1493
2022
Q1
$3.63M Sell
112,914
-5,418
-5% -$174K ﹤0.01% 1546
2021
Q4
$5.28M Buy
118,332
+2,316
+2% +$103K ﹤0.01% 1404
2021
Q3
$5.85M Sell
116,016
-1,022
-0.9% -$51.6K ﹤0.01% 1410
2021
Q2
$9.18M Buy
117,038
+58,249
+99% +$4.57M ﹤0.01% 1211
2021
Q1
$3.36M Buy
58,789
+6,902
+13% +$394K ﹤0.01% 1810
2020
Q4
$4.35M Buy
51,887
+11,110
+27% +$931K ﹤0.01% 1426
2020
Q3
$1.46M Sell
40,777
-845
-2% -$30.3K ﹤0.01% 1927
2020
Q2
$1.01M Sell
41,622
-29,177
-41% -$705K ﹤0.01% 2209
2020
Q1
$1.24M Sell
70,799
-13,407
-16% -$235K ﹤0.01% 1963
2019
Q4
$1.47M Sell
84,206
-19,784
-19% -$344K ﹤0.01% 2149
2019
Q3
$1.59M Buy
103,990
+55,122
+113% +$844K ﹤0.01% 2036
2019
Q2
$1.01M Buy
48,868
+22,549
+86% +$467K ﹤0.01% 2812
2019
Q1
$608K Sell
26,319
-849
-3% -$19.6K ﹤0.01% 3291
2018
Q4
$561K Sell
27,168
-76,228
-74% -$1.57M ﹤0.01% 3210
2018
Q3
$2.25M Buy
103,396
+69,628
+206% +$1.51M ﹤0.01% 2766
2018
Q2
$514K Buy
33,768
+12,536
+59% +$191K ﹤0.01% 3765
2018
Q1
$417K Buy
+21,232
New +$417K ﹤0.01% 3736